News | Coenzyme Q10 may delay egg aging, offering new hope for female fertility
A new review published in Frontiers in Cell and Developmental Biology indicates that coenzyme Q10 (CoQ10) may delay oocyte aging and improve embryo quality by enhancing mitochondrial function and combating oxidative stress, providing a potential intervention pathway for women experiencing age-related fertility decline. The research team also called for larger-scale clinical trials to verify its efficacy and safety.
The review, titled "Exploring the protective effects of coenzyme Q10 on female fertility," was authored by Y. Jiang, Y. Han, P. Qiao, and F. Ren. The study comprehensively analyzed nearly 80 related papers and systematically evaluated the mechanisms and application prospects of coenzyme Q10 in female reproductive health.
The relationship between coenzyme Q10 and oocyte quality
Infertility is a global public health issue, with approximately 17.5% of the adult population experiencing difficulty conceiving naturally. For women, oocyte quality is considered the core factor determining fertility. Oocytes are rich in mitochondria, these "powerhouses" responsible for providing the energy required for maturation, fertilization, and early embryonic development. However, with advancing age, mitochondrial quantity and function gradually decline, and oxidative damage increases, leading to reduced egg quality, higher rates of chromosomal abnormalities, and lower pregnancy success rates.
Although existing assisted reproductive technologies (such as in vitro fertilization, IVF) offer hope to many patients, their success rates remain constrained by the intrinsic biological quality of the oocytes themselves. Therefore, delaying or reversing oocyte aging at the cellular level has become an important research direction in reproductive medicine.
Review findings: the potential and mechanisms of coenzyme Q10
The review points out that coenzyme Q10 is a lipid-soluble compound that serves both as a coenzyme essential for cellular energy production (adenosine triphosphate, ATP) and possesses potent antioxidant effects, capable of scavenging reactive oxygen species (ROS) and preventing cellular damage. Coenzyme Q10 can improve oocyte mitochondrial function by activating key signaling pathways such as SIRT1 and PGC-1alpha, thereby restoring energy metabolism and enhancing developmental potential.
Multiple clinical and experimental studies support this conclusion.
In a randomized controlled trial involving women with poor ovarian reserve, participants receiving coenzyme Q10 supplementation had a greater number of retrievable oocytes, higher fertilization rates, and better embryo quality compared to the control group. The rate of forced embryo transfer cancellation also decreased significantly (from 22.89% to 8.33%). However, the study did not observe significant differences in clinical pregnancy rates and live birth rates, suggesting that further research is still needed to confirm improvements in final reproductive outcomes.
At the laboratory level, an in vitro oocyte culture study found that adding coenzyme Q10 to the culture medium significantly increased the oocyte maturation rate from 48.9% to 75.7%. Additionally, coenzyme Q10 showed synergistic effects when combined with vitamin E, transcutaneous electrical acupoint stimulation, and other non-pharmacological interventions.
In patients with polycystic ovary syndrome (PCOS), coenzyme Q10 supplementation also improved hormonal balance and metabolic parameters.
Dosage, safety, and research gaps
The review suggests that the current common dosage is 200 mg per day for routine IVF cycles, while those with diminished ovarian reserve may increase to 600 mg per day. It is generally considered that 1,200 mg per day is the safe upper limit for humans, but high doses may cause gastrointestinal discomfort. Furthermore, the safety of coenzyme Q10 during pregnancy and lactation has not been fully verified.
The research team emphasized that although current evidence shows coenzyme Q10 can improve oocyte energy metabolism and antioxidant status, thereby enhancing ovarian function and embryo quality, larger-scale randomized controlled clinical trials are still needed to establish standardized dosage and treatment protocols before it can truly enter mainstream clinical treatment systems. Future research should also focus on the synergistic effects of coenzyme Q10 with other treatment modalities to further optimize individualized fertility treatment strategies.
Story source:
Collected from the internet
Author LinkedIVF TeamPublished 2025-10-12
This article used AI assistance; LinkedIVF has not recorded an editorial review for this item. It is not medical advice.
This content is for informational purposes only and does not constitute medical advice. Please consult a licensed physician. Content guidelines & editorial policy
News | Coenzyme Q10 May Delay Egg Aging and Support Female Fertility
News | Coenzyme Q10 may delay egg aging, offering new hope for female fertility
A new review published in Frontiers in Cell and Developmental Biology indicates that coenzyme Q10 (CoQ10) may delay oocyte aging and improve embryo quality by enhancing mitochondrial function and combating oxidative stress, providing a potential intervention pathway for women experiencing age-related fertility decline. The research team also called for larger-scale clinical trials to verify its efficacy and safety.
The review, titled "Exploring the protective effects of coenzyme Q10 on female fertility," was authored by Y. Jiang, Y. Han, P. Qiao, and F. Ren. The study comprehensively analyzed nearly 80 related papers and systematically evaluated the mechanisms and application prospects of coenzyme Q10 in female reproductive health.
The relationship between coenzyme Q10 and oocyte quality
Infertility is a global public health issue, with approximately 17.5% of the adult population experiencing difficulty conceiving naturally. For women, oocyte quality is considered the core factor determining fertility. Oocytes are rich in mitochondria, these "powerhouses" responsible for providing the energy required for maturation, fertilization, and early embryonic development. However, with advancing age, mitochondrial quantity and function gradually decline, and oxidative damage increases, leading to reduced egg quality, higher rates of chromosomal abnormalities, and lower pregnancy success rates.
Although existing assisted reproductive technologies (such as in vitro fertilization, IVF) offer hope to many patients, their success rates remain constrained by the intrinsic biological quality of the oocytes themselves. Therefore, delaying or reversing oocyte aging at the cellular level has become an important research direction in reproductive medicine.
Review findings: the potential and mechanisms of coenzyme Q10
The review points out that coenzyme Q10 is a lipid-soluble compound that serves both as a coenzyme essential for cellular energy production (adenosine triphosphate, ATP) and possesses potent antioxidant effects, capable of scavenging reactive oxygen species (ROS) and preventing cellular damage. Coenzyme Q10 can improve oocyte mitochondrial function by activating key signaling pathways such as SIRT1 and PGC-1alpha, thereby restoring energy metabolism and enhancing developmental potential.
Multiple clinical and experimental studies support this conclusion.
In a randomized controlled trial involving women with poor ovarian reserve, participants receiving coenzyme Q10 supplementation had a greater number of retrievable oocytes, higher fertilization rates, and better embryo quality compared to the control group. The rate of forced embryo transfer cancellation also decreased significantly (from 22.89% to 8.33%). However, the study did not observe significant differences in clinical pregnancy rates and live birth rates, suggesting that further research is still needed to confirm improvements in final reproductive outcomes.
At the laboratory level, an in vitro oocyte culture study found that adding coenzyme Q10 to the culture medium significantly increased the oocyte maturation rate from 48.9% to 75.7%. Additionally, coenzyme Q10 showed synergistic effects when combined with vitamin E, transcutaneous electrical acupoint stimulation, and other non-pharmacological interventions.
In patients with polycystic ovary syndrome (PCOS), coenzyme Q10 supplementation also improved hormonal balance and metabolic parameters.
Dosage, safety, and research gaps
The review suggests that the current common dosage is 200 mg per day for routine IVF cycles, while those with diminished ovarian reserve may increase to 600 mg per day. It is generally considered that 1,200 mg per day is the safe upper limit for humans, but high doses may cause gastrointestinal discomfort. Furthermore, the safety of coenzyme Q10 during pregnancy and lactation has not been fully verified.
The research team emphasized that although current evidence shows coenzyme Q10 can improve oocyte energy metabolism and antioxidant status, thereby enhancing ovarian function and embryo quality, larger-scale randomized controlled clinical trials are still needed to establish standardized dosage and treatment protocols before it can truly enter mainstream clinical treatment systems. Future research should also focus on the synergistic effects of coenzyme Q10 with other treatment modalities to further optimize individualized fertility treatment strategies.
Story source:
Collected from the internet